Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma

被引：0

作者：

Alsina, Maria ^{[1
]}

Fleitas-Kanonnikoff, Tania ^{[2
]}

机构：

[1] Hosp Univ Navarra, Med Oncol Dept, Translat Med Oncol Invest Grp, Navarrabiomed IdiSNA, C-Irunlarrea 3, Pamplona 35008, Spain

[2] Hosp Clin Univ Valencia, Med Oncol Dept, INCLIVA, Valencia, Spain

来源：

MED | 2024年 / 5卷 / 09期

关键词：

CHEMOTHERAPY; PLACEBO;

D O I：

10.1016/j.medj.2024.05.016

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Immunotherapy has revolutionized the treatment landscape of esophageal squamous cell carcinoma. He et al. present the final results of the randomized phase 3 ESCORT-1st trial, confirming positive survival outcomes when adding the anti-PD1 inhibitor camrelizumab to first-line chemotherapy treatment in Chinese patients with esophageal squamous cell cancer.(1)

引用

页码：1038 / 1040

页数：3

共 10 条

[1] Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma [J].

Cabeza-Segura, Manuel ;

Gambardella, Valentina ;

Gimeno-Valiente, Francisco ;

Antonio Carbonell-Asins, Juan ;

Alarcon-Molero, Lorena ;

Gonzalez-Vilanova, Arturo ;

Zuniga-Trejos, Sheila ;

Rentero-Garrido, Pilar ;

Villagrasa, Rosana ;

Gil, Mireia ;

Dura, Ana ;

Richart, Paula ;

Alonso, Noelia ;

Huerta, Marisol ;

Rosello, Susana ;

Roda, Desamparados ;

Tarazona, Noelia ;

Martinez-Ciarpaglini, Carolina ;

Castillo, Josefa ;

Cervantes, Andres ;

Fleitas, Tania .

BRITISH JOURNAL OF CANCER, 2022, 127 (12) :2198-2206

[2] Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma [J].

Doki, Y. ;

Ajani, J. A. ;

Kato, K. ;

Xu, J. ;

Wyrwicz, L. ;

Motoyama, S. ;

Ogata, T. ;

Kawakami, H. ;

Hsu, C. -H. ;

Adenis, A. ;

El Hajbi, F. ;

Di Bartolomeo, M. ;

Braghiroli, M. I. ;

Holtved, E. ;

Ostoich, S. A. ;

Kim, H. R. ;

Ueno, M. ;

Mansoor, W. ;

Yang, W. -C. ;

Liu, T. ;

Bridgewater, J. ;

Makino, T. ;

Xynos, I. ;

Liu, X. ;

Lei, M. ;

Kondo, K. ;

Patel, A. ;

Gricar, J. ;

Chau, I. ;

Kitagawa, Y. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) :449-462

[3] Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial [J].

He, Mingming ;

Wang, Zhiqiang ;

Lu, Jin ;

Bai, Yuxian ;

Mao, Teng ;

Wang, Jun ;

Fan, Qingxia ;

Zhang, Yiping ;

Zhao, Kuaile ;

Chen, Zhendong ;

Gao, Shegan ;

Li, Jiancheng ;

Fu, Zhichao ;

Gu, Kangsheng ;

Liu, Zhihua ;

Wu, Lin ;

Zhang, Xiaodong ;

Feng, Jifeng ;

Niu, Zuoxing ;

Ba, Yi ;

Zhang, Helong ;

Liu, Ying ;

Zhang, Li ;

Min, Xuhong ;

Huang, Jing ;

Cheng, Ying ;

Wang, Dong ;

Sheng, Zhen ;

Zeng, Wanqin ;

Song, Li ;

Xu, Rui-Hua ;

Luo, Huiyan .

MED, 2024, 5 (09) :1137-1149.e3

[4] Tertiary Lymphoid Structure-Associated B Cells Enhance Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy [J].

Hu, Chupeng ;

You, Wenhua ;

Kong, Deyuan ;

Huang, Yedi ;

Lu, Jinying ;

Zhao, Mengya ;

Jin, Yu ;

Peng, Rui ;

Hua, Dong ;

Kuang, Dong-Ming ;

Chen, Yun .

GASTROENTEROLOGY, 2024, 166 (06) :1069-1084

[5] Sex differences in immune responses [J].

Klein, Sabra L. ;

Flanagan, Katie L. .

NATURE REVIEWS IMMUNOLOGY, 2016, 16 (10) :626-638

[6] Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial [J].

Luo, Huiyan ;

Lu, Jin ;

Bai, Yuxian ;

Mao, Teng ;

Wang, Jun ;

Fan, Qingxia ;

Zhang, Yiping ;

Zhao, Kuaile ;

Chen, Zhendong ;

Gao, Shegan ;

Li, Jiancheng ;

Fu, Zhichao ;

Gu, Kangsheng ;

Liu, Zhihua ;

Wu, Lin ;

Zhang, Xiaodong ;

Feng, Jifeng ;

Niu, Zuoxing ;

Ba, Yi ;

Zhang, Helong ;

Liu, Ying ;

Zhang, Li ;

Min, Xuhong ;

Huang, Jing ;

Cheng, Ying ;

Wang, Dong ;

Shen, Yu ;

Yang, Qing ;

Zou, Jianjun ;

Xu, Rui-Hua .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (10) :916-925

[7] Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy [J].

Matson, Vyara ;

Chervin, Carolina Soto ;

Gajewski, Thomas F. .

GASTROENTEROLOGY, 2021, 160 (02) :600-613

[8] Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [J].

Obermannova, R. ;

Alsina, M. ;

Cervantes, A. ;

Leong, T. ;

Lordick, F. ;

Nilsson, M. ;

van Grieken, N. C. T. ;

Vogel, A. ;

Smyth, E. C. .

ANNALS OF ONCOLOGY, 2022, 33 (10) :992-1004

[9] Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study [J].

Sun, Jong-Mu ;

Shen, Lin ;

Shah, Manish A. ;

Enzinger, Peter ;

Adenis, Antoine ;

Doi, Toshihiko ;

Kojima, Takashi ;

Metges, Jean-Philippe ;

Li, Zhigang ;

Kim, Sung-Bae ;

Cho, Byoung Chul ;

Mansoor, Wasat ;

Li, Shau-Hsuan ;

Sunpaweravong, Patrapim ;

Maqueda, Maria Alsina ;

Goekkurt, Eray ;

Hara, Hiroki ;

Antunes, Luis ;

Fountzilas, Christos ;

Tsuji, Akihito ;

Oliden, Victor Castro ;

Liu, Qi ;

Shah, Sukrut ;

Bhagia, Pooja ;

Kato, Ken .

LANCET, 2021, 398 (10302) :759-771

[10] Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study [J].

Xu, Jianming ;

Kato, Ken ;

Raymond, Eric ;

Hubner, Richard A. ;

Shu, Yongqian ;

Pan, Yueyin ;

Park, Sook Ryun ;

Ping, Lu ;

Jiang, Yi ;

Zhang, Jingdong ;

Wu, Xiaohong ;

Yao, Yuanhu ;

Shen, Lin ;

Kojima, Takashi ;

Gotovkin, Evgeny ;

Ishihara, Ryu ;

Wyrwicz, Lucjan ;

Van Cutsem, Eric ;

Jimenez-Fonseca, Paula ;

Lin, Chen -Yuan ;

Wang, Lei ;

Shi, Jingwen ;

Li, Liyun ;

Yoon, Harry H. .

LANCET ONCOLOGY, 2023, 24 (05) :483-495

← 1 →